About us
Products
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Home » News » PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM

PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM

Published: 06 April 2018 12:07

<< Articolo precedente Next Article >>

Related News

PharmaNutra takes part int the Aim Italia...

Great investor interest in the Company’s strategies during the virtual edition of the conference organised...
The Group keeps on growing, unlike the Italian...

The IQVIA figures for the first half of 2020 confirm the stability of PharmaNutra leadership in the nutritional...

Related Products

Gestalys DHA

Gestalys DHA is a nutritional supplement specifically formulated according to LARN (Recommended Nutrition...
Bonecal

Bonecal is a nutritional supplement that contains algal Calcium, Vitamin K2 and Vitamin D3, which aid...

Pharmanutra SpA is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Codice Destinatario Fatturazione Elettronica SUBM70N

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy
Cookie policy
General conditions
Code of ethics
Mod. 231

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

Read Newsletter Disclosure

AWARDS

QUALITY

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More